Yair Melamed
Internal Medicine · Nashua, NHNPI 1184734493
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 161 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AstraZeneca at 25.2% of the total. Among internal medicine clinicians in NH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 161 payments — averaging $18.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$732
- Lilly USA, LLC$304
- Amgen$284
- Novo Nordisk$235
- Pfizer$181
- AbbVie$171
- plus $994 from 16 others
What the payments were for
- Food & beverage$2,901100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 40 | $732 |
| Lilly USA, LLC | 17 | $304 |
| Amgen | 15 | $284 |
| Novo Nordisk | 14 | $235 |
| Pfizer | 11 | $181 |
| AbbVie(2 entities) | 10 | $171 |
| Johnson & Johnson | 7 | $130 |
| Eisai Inc. | 6 | $120 |
| Esperion Therapeutics, Inc. | 6 | $115 |
| Boehringer Ingelheim | 6 | $112 |
| Teva Pharmaceuticals USA, Inc. | 5 | $93 |
| Abbott | 5 | $87 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $82 |
| Biohaven Pharmaceuticals, Inc. | 3 | $58 |
| Merck | 3 | $50 |
| Sanofi-aventis U.S. LLC | 2 | $40 |
| Cequr Corporation | 1 | $26 |
| Antares Pharma, Inc. | 1 | $21 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Smith+Nephew | 1 | $14 |
| Pacira Therapeutics, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
How this compares
$2,901 in reported general payments places this provider in the 95th percentile of 504 internal medicine providers in New Hampshire.
Other internal medicine in Nashua
- Kevin PhoNashua$40K
- Shaji HabeebullaNashua$3K
- Maxim SmirnovNashua$2K
- Suneetha KammilaNashua$1K
- Amjad HusainNashua$970
- Win KyawNashua$640
- Donald RainoneLondonderry$1.9M
- Brian HyettPortsmouth$185K
- Deborah TepperLebanon$133K
- Mark HenschkeNewington$114K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.